000 01400 a2200385 4500
005 20250517205257.0
264 0 _c20181001
008 201810s 0 0 eng d
022 _a1875-8592
024 7 _a10.3233/CBM-181179
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChang, Shu-Jian
245 0 0 _aLower serum CA125 level, negative vascular invasion, and wild BRAF were strongly associated with better 2-year disease-free survival in patients with stage III colorectal cancer who received adjuvant chemotherapy.
_h[electronic resource]
260 _bCancer biomarkers : section A of Disease markers
_c2018
300 _a161-168 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aCA-125 Antigen
_xblood
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aColorectal Neoplasms
_xblood
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeoplasm Staging
650 0 4 _aProto-Oncogene Proteins B-raf
_xgenetics
650 0 4 _aSurvival Rate
650 0 4 _aTime Factors
700 1 _aGe, Xiao-Song
700 1 _aXu, Zhen-Yu
700 1 _aQi, Xiao-Wei
700 1 _aChen, Xiao-Ping
773 0 _tCancer biomarkers : section A of Disease markers
_gvol. 22
_gno. 1
_gp. 161-168
856 4 0 _uhttps://doi.org/10.3233/CBM-181179
_zAvailable from publisher's website
999 _c28201717
_d28201717